Age-related occurrence of inhibitory antibodies to streptococcal pyrogenic superantigens

Pediatrics International

Volumn 38, Issue 1, 1996, Pages 1-7

  Kuwahata, Masato ^a   Imanaka, Hiroyuki ^a   Takei, Syuji ^a   Masuda, Kiminori ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Antibody; Staphylococcal enterotoxin; Streptococcal pyrogenic exotoxin; Superantigen

Indexed keywords

IMMUNOGLOBULIN G; PYROGEN; STAPHYLOCOCCUS ENTEROTOXIN B; STREPTOCOCCUS ANTIGEN; SUPERANTIGEN;

AGING; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CHILD; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOTHERAPY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TOXIC SHOCK SYNDROME;

ADOLESCENT; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; CLONAL ANERGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOTOXINS; FEMALE; HUMANS; INFANT; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; STREPTOCOCCAL INFECTIONS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0029974524     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1996.tb03425.x     Document Type: Article

References (23)

1. Marrack PC, Kappler JW. The staphylococcal enterotoxins and their relatives. Science 1990; 248: 705–11.
2. Janeway CA, Yagi J., Conrad PJ et al. T cell responses to MLs and to bacterial proteins that mimics its behavior. Immunol. Rev. 1989; 107: 61–88.
3. White J., Herman A., Pullen AM, Kubo R., Kappler JW, Marrack PC. The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989; 56: 27–35.
4. Imanishi K., Igarashi H., Uchiyama T. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for major histocompatibility complex class II molecules on accessory cells and identification of Vβ elements in T cells receptor of the toxin-reactive T cells. J. Immunol. 1990; 145: 3170–6.
5. Choi Y., Lafferty JA, Clements JR et al. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J. Exp. Med. 1990; 172: 981–4.
6. Abe J., Kotzin BL, Meissner C. et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J. Exp. Med. 1993; 177: 791–6.
7. Abe J., Kotzin BL, Jujo K. et al. The selective expansion of T cells expressing Vβ2 and Vβ8 in Kawasaki disease. Proc. Natl Acad. Sci. USA. 1992; 89: 4066–70.
8. Takei S., Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J. Clin. Invest. 1993; 91: 602–7.
9. Walker SM, Shaham B., McCurdy DK et al. Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA. J. Rheumatol. 1990; 17: 936–40.
10. Lee ACM, Robbins RN, Bergdoll MS. Isolation of specific and common antibodies to staphylococcal enterotoxins A and E by affinity chromatography. Infect. Immun. 1978; 21: 387–91.
11. David GK. Logistic Regression. Springer-Verlag, New York, 1992.
12. Jerrold HZ. Biostatistical Analysis. 2nd edn. Prentice-Hall, Inc. New Jersey, 1984.
13. Weeks CR, Ferretti JJ. Nucleotide sequence of the type A streptococcal exotoxin (erythrogenic toxin) gene from Streptococcus pyogenes bacteriphage T12. Infect. Immun. 1986; 52: 144–50.
14. Stephen CG, Gregory AB, Patrick MS. Cloning and characterization of the gene, speC, for pyrogenic exotoxin type C from Streptococcus pyogenes. Mol. Gen. Genet. 1988; 212: 66–70.
15. Huang IY, Bergdoll MS. The primary structure of staphylococcal enterotoxin B. J. Biol. Chem. 1970; 245: 3518–25.
16. Abe Y., Nakano S., Nakahara T. et al. Detection of serum antibody by the antimitogen assay against streptococcal erythrogenic toxins. Age distribution in children and the relation to Kawasaki disease. Pediatr. Res. 1990; 27: 11–15.
17. Kappler JW, Staerz U., White J., Marrack PC. Self-tolerance eliminates T cells specific for MLs-modified products of the major histocompatibility complex. Nature 1988; 332: 35–40.
18. Blackman MA, Burgert HG, Woodland DL, Palmer E., Kappler JW, Marrack P. A role for clonal inactivation in T cell tolerance to MLs-1a. Nature 1990; 345: 540–2.
19. Katsukawa C., Harada K., Nakasone C. Epidemiological survey of group A hemolytic streptococci isolated in Osaka during the 21-year period between 1967–1987. J.J.A Inf. D. 1989; 63: 1257–64.
20. Yu CE, Ferretti JJ. Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical streptococcal pyogenes strains. Infect. Immun. 1989; 57: 3715–19.
21. Yu CE, Ferretti JJ. Frequency of erythrogenic toxin B and C genes (speA and speC) among clinical isolates of group A streptococci. Infect. Immun. 1991; 59: 211–15.
22. Newburger JW, Takahashi M., Burns JC et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. N. Engl. J. Med. 1986; 315: 341–7.
23. Silverman ED, Laxer RM, Greenwald M. et al. Intravenous gammaglobulin therapy in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 1990; 33: 1015–22.